149 related articles for article (PubMed ID: 38479444)
1. Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis.
Campos Pacheco JE; Yalovenko T; Riaz A; Kotov N; Davids C; Persson A; Falkman P; Feiler A; Godaly G; Johnson CM; Ekström M; Pilkington GA; Valetti S
J Control Release; 2024 May; 369():231-250. PubMed ID: 38479444
[TBL] [Abstract][Full Text] [Related]
2. Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections.
Valetti S; Xia X; Costa-Gouveia J; Brodin P; Bernet-Camard MF; Andersson M; Feiler A
Nanomedicine (Lond); 2017 Apr; 12(8):831-844. PubMed ID: 28338408
[TBL] [Abstract][Full Text] [Related]
3. Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation.
Jadhav K; Jhilta A; Singh R; Ray E; Sharma N; Shukla R; Singh AK; Verma RK
Biomater Adv; 2023 Nov; 154():213594. PubMed ID: 37657277
[TBL] [Abstract][Full Text] [Related]
4. Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles.
Tenland E; Pochert A; Krishnan N; Umashankar Rao K; Kalsum S; Braun K; Glegola-Madejska I; Lerm M; Robertson BD; Lindén M; Godaly G
PLoS One; 2019; 14(2):e0212858. PubMed ID: 30807612
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence imaging of antibiotic clofazimine encapsulated within mesoporous silica particle carriers: relevance to drug delivery and the effect on its release kinetics.
Angiolini L; Valetti S; Cohen B; Feiler A; Douhal A
Phys Chem Chem Phys; 2018 May; 20(17):11899-11911. PubMed ID: 29666860
[TBL] [Abstract][Full Text] [Related]
6. Reclaiming hijacked phagosomes: Hybrid nano-in-micro encapsulated MIAP peptide ensures host directed therapy by specifically augmenting phagosome-maturation and apoptosis in TB infected macrophage cells.
Sharma A; Vaghasiya K; Gupta P; Gupta UD; Verma RK
Int J Pharm; 2018 Jan; 536(1):50-62. PubMed ID: 29180254
[TBL] [Abstract][Full Text] [Related]
7. Single Crystal FLIM Characterization of Clofazimine Loaded in Silica-Based Mesoporous Materials and Zeolites.
Angiolini L; Cohen B; Douhal A
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212750
[TBL] [Abstract][Full Text] [Related]
8. Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery.
Chen W; Glackin CA; Horwitz MA; Zink JI
Acc Chem Res; 2019 Jun; 52(6):1531-1542. PubMed ID: 31082188
[TBL] [Abstract][Full Text] [Related]
9. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.
Garg T; Goyal AK; Rath G; Murthy RS
Pharm Dev Technol; 2016 Dec; 21(8):951-960. PubMed ID: 26334961
[TBL] [Abstract][Full Text] [Related]
10. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.
Guo Y; Gou K; Yang B; Wang Y; Pu X; Li S; Li H
Molecules; 2019 Sep; 24(19):. PubMed ID: 31575047
[TBL] [Abstract][Full Text] [Related]
11. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles.
Clemens DL; Lee BY; Xue M; Thomas CR; Meng H; Ferris D; Nel AE; Zink JI; Horwitz MA
Antimicrob Agents Chemother; 2012 May; 56(5):2535-45. PubMed ID: 22354311
[TBL] [Abstract][Full Text] [Related]
12. Nano-inside-micro: Disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung.
Wanakule P; Liu GW; Fleury AT; Roy K
J Control Release; 2012 Sep; 162(2):429-37. PubMed ID: 22841795
[TBL] [Abstract][Full Text] [Related]
13. Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice.
Verma RK; Germishuizen WA; Motheo MP; Agrawal AK; Singh AK; Mohan M; Gupta P; Gupta UD; Cholo M; Anderson R; Fourie PB; Misra A
Antimicrob Agents Chemother; 2013 Feb; 57(2):1050-2. PubMed ID: 23183441
[TBL] [Abstract][Full Text] [Related]
14. Porous particles and novel carrier particles with enhanced penetration for efficient pulmonary delivery of antitubercular drugs.
Tse JY; Koike A; Kadota K; Uchiyama H; Fujimori K; Tozuka Y
Eur J Pharm Biopharm; 2021 Oct; 167():116-126. PubMed ID: 34363979
[TBL] [Abstract][Full Text] [Related]
15. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
[TBL] [Abstract][Full Text] [Related]
16. Excipient-Free Pulmonary Delivery and Macrophage Targeting of Clofazimine via Air Jet Micronization.
Brunaugh AD; Jan SU; Ferrati S; Smyth HDC
Mol Pharm; 2017 Nov; 14(11):4019-4031. PubMed ID: 29047275
[TBL] [Abstract][Full Text] [Related]
17. Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.
Rangnekar B; Momin MAM; Eedara BB; Sinha S; Das SC
Int J Pharm; 2019 Oct; 570():118689. PubMed ID: 31513868
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Delivery of Isoniazid in Nanogel-Loaded Chitosan Hybrid Microparticles for Inhalation.
Omar SM; Maziad NA; El-Tantawy NM
J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):78-87. PubMed ID: 30526251
[TBL] [Abstract][Full Text] [Related]
19. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis.
Rawal T; Parmar R; Tyagi RK; Butani S
Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192
[TBL] [Abstract][Full Text] [Related]
20. Applications of mesoporous materials as excipients for innovative drug delivery and formulation.
Shen SC; Ng WK; Chia LS; Dong YC; Tan RB
Curr Pharm Des; 2013; 19(35):6270-89. PubMed ID: 23470004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
